gilead ceo daniel o'day: ending the hiv epidemic is our goal
Published 1 year ago • 3.8K plays • Length 3:47Download video MP4
Download video MP3
Similar videos
-
1:00
gilead ceo: ending the hiv epidemic is our goal #shorts
-
6:00
gilead ceo on 2024 drug pipeline: expect results from around two dozen clinical trials
-
5:52
gilead ceo daniel o'day on remdesivir pricing and ensuring access to treatment
-
4:00
gilead ceo daniel o'day on acquisition of cancer drugmaker immunomedics
-
44:14
global nutrient adequacies with ty beal, phd – diet doctor podcast
-
3:34
how gilead’s pharmaceutical development and manufacturing team delivers transformative medicines
-
4:05
aoc grills gilead ceo over $2,000 price for hiv drug truvada
-
2:14
gilead sciences ceo daniel o'day remarks at 2019 world aids day observances
-
4:48
gilead sciences ceo daniel o'day on the collaboration with biotech firm galapagos
-
5:01
our hiv anthem: helping end the hiv epidemic
-
26:55
grand keynote i daniel o'day, gilead sciences inc and rich karlgaard i tiecon 2021
-
2:16
gilead ceo: we can manufacture enough remdesivir to provide all of the u.s.
-
3:54
gilead ceo on treating covid-19: 'we're not finished with remdesivir'
-
4:03
gilead ceo on promising study results for remdesivir covid-19 treatment
-
2:50
gilead a leader in the hiv medication space: health care researcher
-
2:09
gilead hiv: the care cascade
-
0:31
gilead community collaborations: working together to help end the hiv epidemic
-
0:26
daniel o’day of gilead sciences, inc. on covid-19 efforts
-
4:33
gilead ceo: oral version of covid drug remdesivir in early testing
-
3:34
san francisco community health center x gilead: helping increase access to hiv care
-
1:09
gilead hiv: hiv ends with us
-
10:05
gilead has a complex manufacturing supply chain: former fda chief dr. scott gottlieb